KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Finished Goods (2016 - 2018)

Idexx Laboratories has reported Finished Goods over the past 9 years, most recently at $125.8 million for Q1 2018.

  • Quarterly results put Finished Goods at $125.8 million for Q1 2018, up 0.54% from a year ago — trailing twelve months through Mar 2018 was $125.8 million (up 0.54% YoY), and the annual figure for FY2017 was $113.5 million, down 1.68%.
  • Finished Goods for Q1 2018 was $125.8 million at Idexx Laboratories, up from $113.5 million in the prior quarter.
  • Over the last five years, Finished Goods for IDXX hit a ceiling of $141.2 million in Q3 2015 and a floor of $101.5 million in Q1 2014.
  • Median Finished Goods over the past 5 years was $125.1 million (2017), compared with a mean of $122.8 million.
  • Biggest five-year swings in Finished Goods: rose 26.69% in 2015 and later fell 16.9% in 2016.
  • Idexx Laboratories' Finished Goods stood at $116.6 million in 2014, then grew by 19.19% to $139.0 million in 2015, then fell by 16.9% to $115.5 million in 2016, then decreased by 1.68% to $113.5 million in 2017, then rose by 10.83% to $125.8 million in 2018.
  • The last three reported values for Finished Goods were $125.8 million (Q1 2018), $113.5 million (Q4 2017), and $126.3 million (Q3 2017) per Business Quant data.